The real deal: Using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells

Anticancer Research

Volumn 34, Issue 5, 2014, Pages 2195-2202

  Trendowski, Matthew ^a   Yu, Guowu ^a   Wong, Victoria ^a   Acquafondata, Christopher ^a   Christen, Timothy ^a   Fondy, Thomas P ^a  

^a SYRACUSE UNIVERSITY   (United States)

Author keywords

Cytochalasin B; Leukemia; Preferential damage; Sonodynamic therapy; Ultrasound

Indexed keywords

CYTOCHALASIN B; ANTINEOPLASTIC AGENT;

APOPTOSIS; ARTICLE; CELL COUNTER; CELL DEATH; CELL POPULATION; CELL SIZE; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; CYTOKINESIS; DNA CONTENT; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROMYELOCYTIC LEUKEMIA; SONODYNAMIC THERAPY; ULTRASOUND THERAPY; LEUKEMIA; METHODOLOGY; PREFERENTIAL DAMAGE; U937 CELL LINE; ULTRASOUND;

CYTOCHALASIN B; LEUKEMIA; PREFERENTIAL DAMAGE; SONODYNAMIC THERAPY; ULTRASOUND;

ANTINEOPLASTIC AGENTS; CYTOCHALASIN B; HUMANS; LEUKEMIA; U937 CELLS; ULTRASONIC THERAPY;

EID: 84902961808     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Trendowski M: The promise of sonodynamic therapy. Cancer Metast Rev 2013 Dec 18. [Epub ahead of print].
2. Rosenthal I, Sostaric JZ and Riesz P: Sonodynamic therapy-A review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11(6): 349-363, 2004.
3. Bai W, Shen E and Hu B: Induction of the apoptosis of cancer cell by sonodynamic therapy: A review. Chin J Cancer Res 24(4): 368-373, 2012.
4. Miller MW, Luque AE, Battaglia LF, Mazza S and Everbach EC: Biological and environmental factors affecting ultrasound-induced hemolysis in vitro: 1. HIV macrocytosis. Ultrasound Med Biol 29(1): 77-91, 2003.
5. Woronzoff-Dashkoff KK: The Wright-Giemsa stain. Secrets revealed. Clin Lab Med 221: 15-23, 2002.
6. Kuroki M1, Hachimine K, Abe H, Shibaguchi H, Kuroki M, Maekawa S, Yanagisawa J, Kinugasa T, Tanaka T and Yamashita Y: Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res 27(6A): 3673-3677, 2007.
7. Berridge MV, Herst PM and Tan AS: Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 11: 127-152, 2005.
8. Meng Q, Chen B, Wu W, Shao Z, Gao F and Zhao H: Enhanced antitumor effects of low-frequency ultrasound combined with adriamycin on human leukemia multidrug resistance cell line K562/A02. Chin J Cancer 27(11): 436-439, 2008.
9. Yoshida T, Kondo T, Ogawa R, Feril LB Jr., Zhao QL, Watanabe A and Tsukada K: Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell lilling and an additive enhancement in apoptosis induction in human lymphoma U937 cells. Cancer Chemother Pharmacol 614: 559-567, 2008, 2008.
10. Su X, Wang P, Wang X, Cao B, Li L and Liu Q: Apoptosis of U937 cells induced by hematoporphyrin monomethyl ether-mediated sonodynamic action. Cancer Biother Radiopharm 28: 207-217, 2013.
11. Liang L, Xie S, Jiang L, Jin H, Li S and Liu J: The combined effects of hematoporphyrin monomethyl Ether-SDT and doxorubicin on the proliferation of QBC939 cell lines. Ultrasound Med Biol 39(1): 146-160, 2013.